Legal and Regulatory Framework > United Nations Development Programme (UNDP)

UNDP supports strategic responses to HIV at national, regional and global levels, including through sustainable financing of HIV prevention and treatment. To reduce costs and increase access to HIV treatment and treatment of co-infections, as well as access to relevant technologies, UNDP provides technical and policy support to countries reviewing intellectual property legislation and also provides support to countries involved in WTO accession negotiations or FTA negotiations where there may be intellectual property related implications. To this end, UNDP has been supportive of the Doha Declaration on the TRIPS Agreement and Public Health. UNDP analyzes and disseminates knowledge on the experience of countries in utilizing TRIPS flexibilities to reduce cost and increase access to essential medicines. For example, in 2010, UNDP published a Good Practice Guide dealing with these issues. In early 2011, UNDP, UNAIDS and WHO released a joint Policy Brief on using TRIPS flexibilities to increase access to HIV treatment. UNDP also aims to respond to the needs of developing countries and LDCs in the context of the Global Strategy and Plan of Action approved by the World Health Assembly in 2008 to stimulate research and development into neglected diseases predominantly affecting low and middle income countries.

For more details: http://www.undp.org/content/undp/en/home/librarypage/hiv-aids.html

TRIPS and access to HIV/AIDS drugs

UNDP supports strategic responses to HIV at national, regional and global levels, including through sustainable financing of HIV prevention and treatment. To reduce costs and increase access to HIV treatment and treatment of co-infections, as well as access to relevant technologies, UNDP provides technical and policy support to countries reviewing intellectual property legislation and also provides support to countries involved in WTO accession negotiations or FTA negotiations where there may be intellectual property related implications. To this end, UNDP has been supportive of the Doha Declaration on the TRIPS Agreement and Public Health. UNDP analyzes and disseminates knowledge on the experience of countries in utilizing TRIPS flexibilities to reduce cost and increase access to essential medicines. For example, in 2010, UNDP published a Good Practice Guide dealing with these issues. In early 2011, UNDP, UNAIDS and WHO released a joint Policy Brief on using TRIPS flexibilities to increase access to HIV treatment. UNDP also aims to respond to the needs of developing countries and LDCs in the context of the Global Strategy and Plan of Action approved by the World Health Assembly in 2008 to stimulate research and development into neglected diseases predominantly affecting low and middle income countries.

TRIPS, trade and biodiversity

Contact:
Luciana Mermet, Inclusive 
Globalization Cluster, 
Headquarters, New York
Tel: +1 212 906 5089
Fax: +1 212 906 6471
E-mail: 
maria.luciana.mermet@undp.org

The project aims at building the capacities of developing countries to establish mechanisms for better management of plant variety rights, traditional knowledge and natural resources, and to ensure maintenance of agricultural biodiversity and food security underpinned by a fair and equitable trading system. Specifically, UNDP has developed a tool to assess national legal and policy frameworks that underpin the fulfilment of human rights, with particular focus on the right to food and with a view to establishing adequate plant variety laws. This tool can help countries to promote human rights, establish balanced participatory systems and to learn about rules pertaining to biodiversity, food security and rural livelihoods.

For more details:
http://www.undp.org/content/undp/en/home/ourwork/povertyreduction/focus_areas/
focus_trade_and_investment/intellectual_property/